{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:34:01Z","timestamp":1760060041393,"version":"build-2065373602"},"reference-count":76,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Deutsche Rentenversicherung Nord","award":["RSS 2.10.17.0"],"award-info":[{"award-number":["RSS 2.10.17.0"]}]},{"name":"Schleswig-Holsteinische Vereinigung zur Bek\u00e4mpfung der Tuberkulose und der Lungenkrankheiten e.V.","award":["RSS 2.10.17.0"],"award-info":[{"award-number":["RSS 2.10.17.0"]}]},{"name":"Mukoviszidose Selbsthilfe e.V., Dessau-Ro\u00dflau, Germany","award":["RSS 2.10.17.0"],"award-info":[{"award-number":["RSS 2.10.17.0"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background: The introduction of cystic fibrosis transmembrane conductance regulator modulators, especially the triple therapy elexacaftor, tezacaftor, ivacaftor (ETI), has improved outcomes in people with cystic fibrosis (pwCF), reducing underweight but increasing overweight rates. Objectives: This study investigates the effect of ETI on appetite control, body composition, and energy balance during a 3-week inpatient rehabilitation programme with regular exercise. Methods: In 54 pwCF (38 on ETI, 16 without ETI), changes in body composition (fat mass index, FMI; fat-free mass index, FFMI) and energy balance (calculated from body composition changes) were assessed. Appetite control was evaluated via plasma peptide YY (PYY) levels and post-exercise meal energy intake. Results: The programme significantly increased BMI (+0.3 \u00b1 0.1 kg\/m2; CI 0.1\u20130.4) and energy balance (+4317 \u00b1 1976 kcal\/3 weeks), primarily through FFMI gains (+0.3 \u00b1 0.1 kg\/m2; CI 0.1\u20130.4). Despite higher post-exercise meal energy intake and a tendency towards lower PYY levels in the ETI group, changes in body composition and energy balance did not differ between groups. This is explained by a higher prevalence of exocrine pancreatic insufficiency in the ETI group (92% vs. 50%, p &lt; 0.001). Small sample sizes limit the interpretation of data on appetite control and energy intake. Conclusions: A 3-week inpatient rehabilitation programme improved body composition in pwCF, without resulting in a more positive energy balance with ETI therapy. This is due to a higher prevalence of pancreatic insufficiency in this group.<\/jats:p>","DOI":"10.3390\/nu17152439","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T16:06:17Z","timestamp":1753459577000},"page":"2439","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A 3-Week Inpatient Rehabilitation Programme Improves Body Composition in People with Cystic Fibrosis with and Without Elexacaftor\/Tezacaftor\/Ivacaftor Therapy"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8074-731X","authenticated-orcid":false,"given":"Jana","family":"Koop","sequence":"first","affiliation":[{"name":"Institute of Human Nutrition and Food Science, Kiel University, D\u00fcsternbrooker Weg 17, 24105 Kiel, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2186-9269","authenticated-orcid":false,"given":"Wolfgang","family":"Gruber","sequence":"additional","affiliation":[{"name":"Institute of Human Nutrition and Food Science, Kiel University, D\u00fcsternbrooker Weg 17, 24105 Kiel, Germany"},{"name":"Pediatric Pulmonology and Sleep Medicine, Cystic Fibrosis Center, Children\u2019s Hospital, University of Duisburg-Essen, Hufelandstrasse 55, 45122 Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska A.","family":"H\u00e4gele","sequence":"additional","affiliation":[{"name":"Institute of Human Nutrition and Food Science, Kiel University, D\u00fcsternbrooker Weg 17, 24105 Kiel, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Norman","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Gerontology, German Institute of Human Nutrition Potsdam-Rehbr\u00fccke, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany"},{"name":"Department of Geriatrics and Medical Gerontology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Reinickendorfer Strasse 61-62, 13347 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catrin","family":"Herpich","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Gerontology, German Institute of Human Nutrition Potsdam-Rehbr\u00fccke, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany"},{"name":"Department of Geriatrics and Medical Gerontology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Reinickendorfer Strasse 61-62, 13347 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Dewey","sequence":"additional","affiliation":[{"name":"Strandklinik St. Peter-Ording, Fritz-Wischer-Stra\u00dfe 3, 25826 St. Peter-Ording, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Falkenberg","sequence":"additional","affiliation":[{"name":"Fachklinik Satteld\u00fcne DRV Nord, Tanenwai 32, 25946 Nebel, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Schnabel","sequence":"additional","affiliation":[{"name":"Fachklinik Satteld\u00fcne DRV Nord, Tanenwai 32, 25946 Nebel, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkhard","family":"Weisser","sequence":"additional","affiliation":[{"name":"Department of Sportsmedicine, Kiel University, Olshausenstrasse 74, 24118 Kiel, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4781-2386","authenticated-orcid":false,"given":"Mario","family":"Hasler","sequence":"additional","affiliation":[{"name":"Applied Statistics, Kiel University, Hermann-Rodewald-Strasse 9, 24098 Kiel, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8318-9448","authenticated-orcid":false,"given":"Anja","family":"Bosy-Westphal","sequence":"additional","affiliation":[{"name":"Institute of Human Nutrition and Food Science, Kiel University, D\u00fcsternbrooker Weg 17, 24105 Kiel, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic Fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"unstructured":"Naehrlich, L., Burkhart, M., Basler, C., Dittrich, A.-M., Ellemunter, H., Hebestreit, H., Nitsche, O., Held, I., Smaczny, C., and Sutharsan, S. (2024). German Cystic Fibrosis Registry-Annual Report 2023, Mukoviszidose e.V. & Mukoviszidose Institut GmbH.","key":"ref_2"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The Future of Cystic Fibrosis Care: A Global Perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/thorax.56.10.746","article-title":"Wasting as an Independent Predictor of Mortality in Patients with Cystic Fibrosis","volume":"56","author":"Sharma","year":"2001","journal-title":"Thorax"},{"unstructured":"European Medicines Agency (2024, July 09). Kalydeco. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/kalydeco#authorisation-details.","key":"ref_5"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100690","DOI":"10.1016\/j.lanepe.2023.100690","article-title":"Impact of Elexacaftor\/Tezacaftor\/Ivacaftor on Lung Function, Nutritional Status, Pulmonary Exacerbation Frequency and Sweat Chloride in People with Cystic Fibrosis: Real-World Evidence from the German CF Registry","volume":"32","author":"Sutharsan","year":"2023","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(23)01609-4","article-title":"CFTR Modulator Therapy: Transforming the Landscape of Clinical Care in Cystic Fibrosis","volume":"402","author":"Robinson","year":"2023","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jand.2020.03.014","article-title":"Effect of CFTR Modulators on Anthropometric Parameters in Individuals with Cystic Fibrosis: An Evidence Analysis Center Systematic Review","volume":"121","author":"Bailey","year":"2021","journal-title":"J. Acad. Nutr. Diet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and Safety of the Elexacaftor plus Tezacaftor plus Ivacaftor Combination Regimen in People with Cystic Fibrosis Homozygous for the F508del Mutation: A Double-Blind, Randomised, Phase 3 Trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"unstructured":"European Medicines Agency (2025, June 12). Kaftrio. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/kaftrio#authorisation-details.","key":"ref_10"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jpeds.2018.05.018","article-title":"Energy Balance and Mechanisms of Weight Gain with Ivacaftor Treatment of Cystic Fibrosis Gating Mutations","volume":"201","author":"Stallings","year":"2018","journal-title":"J. Pediatr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/ppul.26388","article-title":"The Impact of Elexacaftor\/Tezacaftor\/Ivacaftor on Body Composition in a Small Cohort of Youth with Cystic Fibrosis","volume":"58","author":"Granados","year":"2023","journal-title":"Pediatr. Pulmonol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"101466","DOI":"10.1016\/j.diabet.2023.101466","article-title":"Effects of Elexacaftor \/ Tezacaftor \/ Ivacaftor Triple Combination Therapy on Glycaemic Control and Body Composition in Patients with Cystic Fibrosis-Related Diabetes","volume":"49","author":"Grancini","year":"2023","journal-title":"Diabetes Metab."},{"doi-asserted-by":"crossref","unstructured":"Hevilla, F., Porras, N., Gir\u00f3n, M.V., Garc\u00eda-Olivares, M., Padial, M., S\u00e1nchez-Torralvo, F.J., Olveira, C., and Olveira, G. (2024). Impact of Elexacaftor-Tezacaftor-Ivacaftor Therapy on Body Composition, Dietary Intake, Biomarkers, and Quality of Life in People with Cystic Fibrosis: A Prospective Observational Study. Nutrients, 16.","key":"ref_14","DOI":"10.3390\/nu16193293"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/j.clnu.2023.10.015","article-title":"A Prospective Study to Assess the Impact of a Novel CFTR Therapy Combination on Body Composition in Patients with Cystic Fibrosis with F508del Mutation","volume":"42","author":"Marazuela","year":"2023","journal-title":"Clin. Nutr."},{"doi-asserted-by":"crossref","unstructured":"Merino S\u00e1nchez-Ca\u00f1ete, A., L\u00f3pez C\u00e1rdenes, C.M., Vicente Santamar\u00eda, S., Guti\u00e9rrez Mart\u00ednez, J.R., Su\u00e1rez Gonz\u00e1lez, M., \u00c1lvarez Merino, M., and Gonz\u00e1lez Jim\u00e9nez, D. (2024). Increased Fat Mass and Obesity Risk after Elexacaftor-Tezacaftor-Ivacaftor Therapy in Young Adults with Cystic Fibrosis. Front. Nutr., 11.","key":"ref_16","DOI":"10.3389\/fnut.2024.1477674"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"112425","DOI":"10.1016\/j.nut.2024.112425","article-title":"Impact of CFTR Modulator Therapy on Body Composition as Assessed by Thoracic Computed Tomography: A Follow-up Study","volume":"123","author":"Marazuela","year":"2024","journal-title":"Nutrition"},{"doi-asserted-by":"crossref","unstructured":"Trost, S.U., Harindhanavudhi, T., Ankireddypalli, A., Wang, Q., Simrah, A., Avula, S., and Moheet, A. (2024, July 17). Elexacaftor\/Tezacaftor\/Ivacator Effect on Bone Density and Body Composition\u2013A Retrospective Analysis. 2024, preprint, Available online: https:\/\/ssrn.com\/abstract=4882738.","key":"ref_18","DOI":"10.2139\/ssrn.4882738"},{"doi-asserted-by":"crossref","unstructured":"Westh\u00f6lter, D., Haubold, J., Welsner, M., Salh\u00f6fer, L., Wienker, J., Sutharsan, S., Stra\u00dfburg, S., Taube, C., Umutlu, L., and Schaarschmidt, B.M. (2024). Elexacaftor\/Tezacaftor\/Ivacaftor Influences Body Composition in Adults with Cystic Fibrosis: A Fully Automated CT-Based Analysis. Sci. Rep., 14.","key":"ref_19","DOI":"10.1038\/s41598-024-59622-2"},{"key":"ref_20","first-page":"1535","article-title":"One-Year Assessment of Body Composition in Cystic Fibrosis Patients on Elexacaftor-Tezacaftor-Ivacaftor","volume":"7","author":"Zamponi","year":"2023","journal-title":"Clin. Case Rep. Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ppul.26243","article-title":"Effect of Trikafta on Bone Density, Body Composition and Exercise Capacity in CF: A Pilot Study","volume":"58","author":"Gur","year":"2023","journal-title":"Pediatr. Pulmonol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1002\/ppul.27272","article-title":"Effects on Growth, Weight and Body Composition after CFTR Modulators in Children with Cystic Fibrosis","volume":"59","year":"2024","journal-title":"Pediatr. Pulmonol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jcf.2023.06.002","article-title":"Weight a Minute: Exploring the Effect on Weight and Body Composition after the Initiation of Elexacaftor\/Tezacaftor\/Ivacaftor in Adults with CF","volume":"22","author":"Proud","year":"2023","journal-title":"J. Cyst. Fibros."},{"doi-asserted-by":"crossref","unstructured":"Sheikh, S., Zemel, B.S., Stallings, V.A., Rubenstein, R.C., and Kelly, A. (2014). Body Composition and Pulmonary Function in Cystic Fibrosis. Front. Pediatr., 2.","key":"ref_24","DOI":"10.3389\/fped.2014.00033"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clnu.2023.12.017","article-title":"ESPEN-ESPGHAN-ECFS Guideline on Nutrition Care for Cystic Fibrosis","volume":"43","author":"Wilschanski","year":"2024","journal-title":"Clin. Nutr."},{"unstructured":"(2024, November 14). German Pension Insurance Concept for the Inpatient Rehabilitation of Children and Adolescents with Cystic Fibrosis. Available online: https:\/\/www.google.com\/url?sa=t&source=web&rct=j&opi=89978449&url=https:\/\/www.deutsche-rentenversicherung.de\/SharedDocs\/Downloads\/DE\/Experten\/infos_reha_einrichtungen\/konzepte_systemfragen\/konzepte\/konzept_kinder_mukoviszidose.pdf%3F__blob%3DpublicationFile%26v%3D1&ved=2ahUKEwidqIrq1tuJAxU8BdsEHdqaALwQFnoECDMQAQ&usg=AOvVaw1cfIUZpydc_qHtvf26K3KL.","key":"ref_26"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00431-021-03943-1","article-title":"The Effect of an Intensive Residential Rehabilitation Program on Body Composition in Patients with Cystic Fibrosis","volume":"180","author":"Declercq","year":"2021","journal-title":"Eur. J. Pediatr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/CPT.0000000000000016","article-title":"Exercise and Habitual Physical Activity for People With Cystic Fibrosis: Expert Consensus, Evidence-Based Guide for Advising Patients","volume":"26","author":"Swisher","year":"2015","journal-title":"Cardiopulm. Phys. Ther. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/obr.12257","article-title":"Appetite Control and Energy Balance: Impact of Exercise","volume":"16","author":"Blundell","year":"2015","journal-title":"Obes. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jcf.2025.03.505","article-title":"Presentation WS03.02 High-Intensity Interval Training and Moderate-Intensity Continuous Training Are Equivalent in Improving Exercise Capacity at Submaximal Intensity in Adults with Cystic Fibrosis","volume":"24","author":"Gruber","year":"2025","journal-title":"J. Cyst. Fibros."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-Ethnic Reference Values for Spirometry for the 3-95-Yr Age Range: The Global Lung Function 2012 Equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/adc.46.246.144","article-title":"Pulmonary Function and Response to Exercise in Cystic Fibrosis","volume":"46","author":"Godfrey","year":"1971","journal-title":"Arch. Dis. Child."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000439057","article-title":"Statement on Exercise Testing in Cystic Fibrosis","volume":"90","author":"Hebestreit","year":"2015","journal-title":"Respiration"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/sj.ijo.0801083","article-title":"Reproducibility, Power and Validity of Visual Analogue Scales in Assessment of Appetite Sensations in Single Test Meal Studies","volume":"24","author":"Flint","year":"2000","journal-title":"Int. J. Obes."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/ajcn\/76.5.1023","article-title":"Inverse Association between the Effect of Carbohydrates on Blood Glucose and Subsequent Short-Term Food Intake in Young Men","volume":"76","author":"Anderson","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"doi-asserted-by":"crossref","unstructured":"Beaulieu, K., Oustric, P., Alkahtani, S., Alhussain, M., Pedersen, H., Quist, J.S., F\u00e6rch, K., and Finlayson, G. (2020). Impact of Meal Timing and Chronotype on Food Reward and Appetite Control in Young Adults. Nutrients, 12.","key":"ref_36","DOI":"10.3390\/nu12051506"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.appet.2006.08.002","article-title":"Appetite Sensations and Satiety Quotient: Predictors of Energy Intake and Weight Loss","volume":"48","author":"Drapeau","year":"2007","journal-title":"Appetite"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/appe.1997.0096","article-title":"A Satiety Quotient: A Formulation to Assess the Satiating Effect of Food","volume":"29","author":"Green","year":"1997","journal-title":"Appetite"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1073\/pnas.4.12.370","article-title":"A Biometric Study of Human Basal Metabolism","volume":"4","author":"Harris","year":"1918","journal-title":"Proc. Natl. Acad. Sci. USA"},{"unstructured":"European Parliament and Council (2011). Regulation (EU) No 1169\/2011 of the European Parliament and of the Council of 25 October 2011 on the Provision of Food Information to Consumers.","key":"ref_40"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1749-6632.2000.tb06482.x","article-title":"Body Fat Content Influences the Body Composition Response to Nutrition and Exercise","volume":"904","author":"Forbes","year":"2000","journal-title":"Ann. N. Y Acad. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3945\/ajcn.114.087122","article-title":"An Objective Estimate of Energy Intake during Weight Gain Using the Intake-Balance Method","volume":"100","author":"Gilmore","year":"2014","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/ajcn\/85.1.73","article-title":"Validation Study of Energy Expenditure and Intake during Calorie Restriction Using Doubly Labeled Water and Changes in Body Composition","volume":"85","author":"DeLany","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"E441","DOI":"10.1152\/ajpendo.00290.2011","article-title":"Approaches for Quantifying Energy Intake and %calorie Restriction during Calorie Restriction Interventions in Humans: The Multicenter CALERIE Study","volume":"302","author":"Racette","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: A Flexible Statistical Power Analysis Program for the Social, Behavioral, and Biomedical Sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jcf.2013.06.005","article-title":"Interval Exercise Training in Cystic Fibrosis -- Effects on Exercise Capacity in Severely Affected Adults","volume":"13","author":"Gruber","year":"2014","journal-title":"J. Cyst. Fibros."},{"unstructured":"R Core Team (2024, October 01). R: The R Project for Statistical Computing. Available online: https:\/\/www.r-project.org\/.","key":"ref_47"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1198\/jasa.2001.s411","article-title":"Mixed-Effects Models in S and S-Plus","volume":"96","author":"Carey","year":"2002","journal-title":"J. Am. Stat. Assoc."},{"doi-asserted-by":"crossref","unstructured":"Carroll, R.J., and Ruppert, D. (1988). Transformation and Weighting in Regression, Springer.","key":"ref_49","DOI":"10.1007\/978-1-4899-2873-3"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1477-2574.2009.00134.x","article-title":"Importance of Nutritional Management in Diseases with Exocrine Pancreatic Insufficiency","volume":"11","author":"Ockenga","year":"2009","journal-title":"HPB"},{"unstructured":"Bretz, F., Hothorn, T., and Westfall, P.H. (2011). Multiple Comparisons Using R, CRC Press.","key":"ref_51"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/bimj.200810425","article-title":"Simultaneous Inference in General Parametric Models","volume":"50","author":"Hothorn","year":"2008","journal-title":"Biom. J."},{"unstructured":"WHO (2024, September 30). A Healthy Lifestyle-WHO Recommendations. Available online: https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/a-healthy-lifestyle---who-recommendations.","key":"ref_53"},{"key":"ref_54","first-page":"1178","article-title":"Genetic Determination of Exocrine Pancreatic Function in Cystic Fibrosis","volume":"50","author":"Kristidis","year":"1992","journal-title":"Am. J. Hum. Genet."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jcf.2022.08.008","article-title":"Cystic Fibrosis Transmembrane Conductance Regulator Modulators and the Exocrine Pancreas: A Scoping Review","volume":"22","author":"Ramsey","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000538606","article-title":"Improved Nutritional Outcomes and Gastrointestinal Symptoms in Adult Cystic Fibrosis Patients Treated with Elexacaftor\/Tezacaftor\/Ivacaftor","volume":"42","author":"Stastna","year":"2024","journal-title":"Dig. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcf.2021.11.012","article-title":"Effect of Elexacaftor-Tezacaftor-Ivacaftor on Body Weight and Metabolic Parameters in Adults with Cystic Fibrosis","volume":"21","author":"Petersen","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref_58","first-page":"100829","article-title":"Patient Perspectives Following Initiation of Elexacaftor-Tezacaftor-Ivacaftor in People with Cystic Fibrosis and Advanced Lung Disease","volume":"80","author":"Martin","year":"2021","journal-title":"Respir. Med. Res."},{"doi-asserted-by":"crossref","unstructured":"Bailey, J. (2021). Nutritional and Metabolic Effects of Elexacaftor\/Tezacaftor\/Ivacaftor in Adults and Adolescents with Cystic Fibrosis. [Ph.D. Thesis, University of Alabama at Birmingham].","key":"ref_59","DOI":"10.1016\/S1569-1993(21)01641-6"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jcf.2023.06.010","article-title":"Body Mass Index and Nutritional Intake Following Elexacaftor\/Tezacaftor\/Ivacaftor Modulator Therapy in Adults with Cystic Fibrosis","volume":"22","author":"Caley","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nature00887","article-title":"Gut Hormone PYY(3-36) Physiologically Inhibits Food Intake","volume":"418","author":"Batterham","year":"2002","journal-title":"Nature"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jcf.2019.08.015","article-title":"Energy Balance and Obesity in Individuals with Cystic Fibrosis","volume":"18","author":"Litvin","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"6397","DOI":"10.1007\/s00405-024-08888-3","article-title":"Cystic Fibrosis-Related Chronic Rhinosinusitis: The Key Role of a Comprehensive Evaluation in the Era of Highly Effective Modulator Therapy","volume":"281","author":"Minzoni","year":"2024","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/alr.23209","article-title":"Olfaction, Body Mass Index, and Quality of Life with Cystic Fibrosis Combination Therapy","volume":"13","author":"Tervo","year":"2023","journal-title":"Int. Forum Allergy Rhinol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/alr.22891","article-title":"Olfaction before and after Initiation of Elexacaftor-Tezacaftor-Ivacaftor in a Cystic Fibrosis Cohort","volume":"12","author":"Bacon","year":"2022","journal-title":"Int. Forum Allergy Rhinol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1016\/j.jcf.2021.09.014","article-title":"Olfactory Dysfunction in Cystic Fibrosis: Impact of CFTR Modulator Therapy","volume":"21","author":"Beswick","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/07315724.2004.10719381","article-title":"The Effects of High Protein Diets on Thermogenesis, Satiety and Weight Loss: A Critical Review","volume":"23","author":"Halton","year":"2004","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_68","first-page":"743","article-title":"Effects of a High-Protein Meal (Meat) and a High-Carbohydrate Meal (Vegetarian) on Satiety Measured by Automated Computerized Monitoring of Subsequent Food Intake, Motivation to Eat and Food Preferences","volume":"14","author":"Barkeling","year":"1990","journal-title":"Int. J. Obes."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1006\/appe.1993.1034","article-title":"Effects of Flavor and Macronutrient Composition of Food Servings on Liking, Hunger and Subsequent Intake","volume":"21","author":"Johnson","year":"1993","journal-title":"Appetite"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/ajcn\/82.1.41","article-title":"A High-Protein Diet Induces Sustained Reductions in Appetite, Ad Libitum Caloric Intake, and Body Weight despite Compensatory Changes in Diurnal Plasma Leptin and Ghrelin Concentrations","volume":"82","author":"Weigle","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s43016-022-00688-4","article-title":"Ad Libitum Meal Energy Intake Is Positively Influenced by Energy Density, Eating Rate and Hyper-Palatable Food across Four Dietary Patterns","volume":"4","author":"Fazzino","year":"2023","journal-title":"Nat. Food"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/oby.23133","article-title":"Impact of Energy Turnover on the Regulation of Energy and Macronutrient Balance","volume":"29","year":"2021","journal-title":"Obesity"},{"key":"ref_73","first-page":"5","article-title":"Improvement in Body Composition Following a Supervised Exercise-Training Program of Adult Patients with Cystic Fibrosis","volume":"75","author":"Godin","year":"2019","journal-title":"Respir. Med. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/j.jcf.2021.08.004","article-title":"Rethinking Physical Exercise Training in the Modern Era of Cystic Fibrosis: A Step towards Optimising Short-Term Efficacy and Long-Term Engagement","volume":"21","author":"Gruet","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref_75","first-page":"CD002768","article-title":"Physical Activity and Exercise Training in Cystic Fibrosis","volume":"8","author":"Radtke","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.clnesp.2023.08.028","article-title":"Effect of 18 months elexacaftor-tezacaftor-ivacaftor on body mass index and glycemic control in adults with cystic fibrosis","volume":"58","author":"Taelman","year":"2023","journal-title":"Clin. Nutr. ESPEN"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/15\/2439\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:16:23Z","timestamp":1760033783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/15\/2439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":76,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["nu17152439"],"URL":"https:\/\/doi.org\/10.3390\/nu17152439","relation":{},"ISSN":["2072-6643"],"issn-type":[{"type":"electronic","value":"2072-6643"}],"subject":[],"published":{"date-parts":[[2025,7,25]]}}}